Back to search
FDAFDA · Food and drugs·Recall number D-0800-2020

Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302

Published January 29, 2020 · Recall initiated: August 24, 2019

Summary

FDA records drug Class II recall D-0800-2020, published January 29, 2020 and initiated August 24, 2019. Recalling firm: Tuscano and Delucia Group (DBA Entropic Labs); Status: Terminated; Reported quantity: 60; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tuscano and Delucia Group (DBA Entropic Labs)
Distributor
Nationwide within the United States
UPC
651074545302
Lot
All lots
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302 recalled?

Yes. FDA published recall D-0800-2020 on January 29, 2020. Reported hazard: Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 651074545302.